Neurophth Therapeutics Receives IND Clearance to Initiate Clinical Trial for China AAV-ND4 Gene Therapy NR082 in Leber Hereditary Optic Neuropathy

PR Newswire
January 19, 2022 — 22:30 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America California China currency europe healthcare manufacturing Renminbi Shanghai Suzhou Wuhan Yuan

Related News:

Inaugural ‘Korea Medical Innovation Research Forum’ regular seminar, a success

April 19, 2024 — 21:00

Infosys to Acquire Leading Engineering R&D services provider, in-tech

April 18, 2024 — 21:42

LG STRENGTHENS EUROPEAN PRESENCE WITH ITS KITCHEN SOLUTIONS SHOWCASE AT MDW 2024

April 18, 2024 — 09:00

National University of Singapore’s IES, The Rockefeller Foundation Advance Renewable Energy Connectivity in Southeast Asia

April 18, 2024 — 09:00

BitoGroup’s Strategic Expansion Doubles Market Reach in Taiwan

April 17, 2024 — 18:30

Students from JA Greece Win 2024 De La Vega Global Entrepreneurship Award

April 17, 2024 — 03:00

Orion X7 Unleashed: A Celebration of Innovation at the Sunseeker Lawn Banquet

April 17, 2024 — 02:34

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

April 13, 2024 — 20:00

IOT Data Hackathon Award Ceremony – Data-driven Economy: Unleashing the Powerhouse of Possibilities

April 13, 2024 — 18:30